10th Annual Symposium
Epigenetics and Epigenomics in Lysosomal Disorders:
GRIDS 2024
Epigenetics and Epigenomics in Lysosomal Disorders:
Bridging Molecular Insights and Therapeutic Innovations
November 24th – 25th, 2024
Capital One Hall · 7750 Capital One Tower Road · Tysons, Virginia, 22102
About the Event
10th Annual GRIDSymposium
Event Overview
The 10th Annual GRIDSymposium convenes global experts to discuss Epigenetics and Epigenomics in Lysosomal Disorders, bridging molecular insights with therapeutic innovations. Through two days of keynote lectures, research presentations, and a clinical workshop, GRIDS 2024 fosters interdisciplinary collaboration that drives innovation and improves patient outcomes in lysosomal storage and rare genetic disorders.
Program Highlights
- Overview of Epigenetics and Epigenomics in Lysosomal Disorders
- Epigenetic and Epigenomics signature in Lysosomal Disorders pathology
- Epigenetic Modifiers as Therapeutic Targets
- Understanding the global differences in Lysosomal Disorders for patient care
- Fabry Clinical Workshop (By invitation only)
Keynote Presentation
David G. Warnock, MD
Professor of Medicine (Emeritus), University of Alabama at Birmingham, AL, USA
Young Investigator Awards
David Smerkous
AI PhD Candidate, Oregon State University, OR, USA
Majdolen (Joleen) Istaiti, B.Sc., MBA
Clinical Study Coordinator at Gaucher Unit, Shaare Zedek Medical Center, Jerusalem, Israel
Sessions
Agenda Overview
Day 1 — November 24th, 2024
Session I: Overview of Epigenetics and Epigenomics in LDs
Session II: Epigenetic and Epigenomics Signature in LDs Pathology
Session III: Epigenetic Modifiers as Therapeutic Targets
Day 2 — November 25th, 2024
Session IV: Understanding the Global Differences in LDs for Patient Care
Education Grant
This Program is Sponsored By
Lilly
Continuing Education
Enduring CMEs
Session 1
Optimizing the Efficacy and Safety of Therapy for Fabry Disease
Session 2
Overview of Epigenetics and Epigenomics in Lysosomal Disorders
Session 3
Epigenetic and Epigenomics Signature in Lysosomal Disorders Pathology
Session 4
Epigenetic Modifiers as Therapeutic Targets
Session 5